196 related articles for article (PubMed ID: 30583724)
1. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Kim J; Luo W; Wang M; Wegman-Ostrosky T; Frone MN; Johnston JJ; Nickerson ML; Rotunno M; Li SA; Achatz MI; Brodie SA; Dean M; de Andrade KC; Fortes FP; Gianferante M; Khincha P; McMaster ML; McReynolds LJ; Pemov A; Pinheiro M; Santiago KM; Alter BP; Caporaso NE; Gadalla SM; Goldin LR; Greene MH; Loud J; Yang XR; Freedman ND; Gapstur SM; Gaudet MM; Calista D; Ghiorzo P; Fargnoli MC; Nagore E; Peris K; Puig S; Landi MT; Hicks B; Zhu B; Liu J; Sampson JN; Chanock SJ; Mirabello LJ; Morton LM; Biesecker LG; Tucker MA; Savage SA; Goldstein AM; Stewart DR
Genome Med; 2018 Dec; 10(1):99. PubMed ID: 30583724
[TBL] [Abstract][Full Text] [Related]
2. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
[TBL] [Abstract][Full Text] [Related]
4. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR
JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712
[TBL] [Abstract][Full Text] [Related]
6. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
Chetruengchai W; Shotelersuk V
J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
[TBL] [Abstract][Full Text] [Related]
7. Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia-associated variants.
Paludan-Müller C; Ahlberg G; Ghouse J; Herfelt C; Svendsen JH; Haunsø S; Kanters JK; Olesen MS
Clin Genet; 2017 Jan; 91(1):63-72. PubMed ID: 27538377
[TBL] [Abstract][Full Text] [Related]
8. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
9. Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List.
Huang Y; Liu B; Shi J; Zhao S; Xu K; Sun L; Chen N; Tian W; Zhang J; Wu N
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143288
[TBL] [Abstract][Full Text] [Related]
10. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients.
Vargas-Parra G; Del Valle J; Rofes P; Gausachs M; Stradella A; Moreno-Cabrera JM; Velasco A; Tornero E; Menéndez M; Muñoz X; Iglesias S; López-Doriga A; Azuara D; Campos O; Cuesta R; Darder E; de Cid R; González S; Teulé A; Navarro M; Brunet J; Capellá G; Pineda M; Feliubadaló L; Lázaro C
Hum Mutat; 2020 Dec; 41(12):2128-2142. PubMed ID: 32906215
[TBL] [Abstract][Full Text] [Related]
12. Systematic Evaluation of
Kashiwa A; Aiba T; Makimoto H; Shimamoto K; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Yagihara N; Watanabe H; Aizawa Y; Makiyama T; Itoh H; Hayashi K; Yamagishi M; Sumitomo N; Yoshinaga M; Morita H; Ohe T; Miyamoto Y; Makita N; Yasuda S; Kusano K; Ohno S; Horie M; Shimizu W
Circ Genom Precis Med; 2020 Sep; ():. PubMed ID: 32936022
[No Abstract] [Full Text] [Related]
13. The rate of secondary genomic findings in the Saudi population.
Aloraini T; Alsubaie L; Alasker S; Al Muitiri A; Alswaid A; Eyiad W; Al Mutairi F; Ababneh F; Alfadhel M; Alfares A
Am J Med Genet A; 2022 Jan; 188(1):83-88. PubMed ID: 34515413
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.
van Marcke C; Collard A; Vikkula M; Duhoux FP
Crit Rev Oncol Hematol; 2018 Dec; 132():138-144. PubMed ID: 30447919
[TBL] [Abstract][Full Text] [Related]
15. Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants.
Fridman H; Behar DM; Carmi S; Levy-Lahad E
Genet Med; 2020 Mar; 22(3):646-653. PubMed ID: 31624327
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
[TBL] [Abstract][Full Text] [Related]
17. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract][Full Text] [Related]
18. Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time.
van Rooij J; Arp P; Broer L; Verlouw J; van Rooij F; Kraaij R; Uitterlinden A; Verkerk AJMH
Genet Med; 2020 Nov; 22(11):1812-1820. PubMed ID: 32665702
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.
Stroeks SLVM; Hellebrekers DMEI; Claes GRF; Tayal U; Krapels IPC; Vanhoutte EK; van den Wijngaard A; Henkens MTHM; Ware JS; Heymans SRB; Brunner HG; Verdonschot JAJ
Genet Med; 2021 Nov; 23(11):2186-2193. PubMed ID: 34194005
[TBL] [Abstract][Full Text] [Related]
20. Cancer carrier screening in the general population using whole-genome sequencing.
Chang YS; Chao DS; Chung CC; Chou YP; Chang CM; Lin CL; Chu HW; Chen HD; Liu TY; Juan YH; Chang SJ; Chang JG
Cancer Med; 2023 Jan; 12(2):1972-1983. PubMed ID: 35861108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
